References
- Centre for Epidemiology, Swedish National Board of Health and Welfare. Cancer incidence in Sweden 1996. Stockholm: Swedish National Board of Health and Welfare; 1998.
- Sagalowsky AI, Jarrett TW. Management of urothelial tumors of the renal pelvis and ureter. Campbell's urology8th ed, PC Walsh, AB Retik, ED Vaughan, Jr, AJ Wein. WB Saunders Inc, Philadelphia, PA 2002; 2847
- Månsson Å, Anderson H, Colleen S. Time lag to diagnosis of bladder cancer—influence of psychosocial parameters and level of health-care provision. Scand J Urol Nephrol 1993; 27: 363–9
- Wallace DMA, Bryan RT, Dunn JA, Begum G, Bathers S. Delay and survival in bladder cancer. BJU Int 2002; 89: 868–78
- Hermanek P, Sobin L. TNM classification of malignant tumors: renal pelvis and ureter4th ed. Springer-Verlag, New York 1992; 151
- Mostofi FK, Davis CJ, Sesterhenn I. World Health Organization. International histological classification of tumours. Histological typing of urinary bladder tumours2nd ed. Springer, Berlin 1999
- Epstein JI, Amin MB, Reuter VR, Mostofi FK, and the Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998;22:1435–48.
- Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Pathology and genetics of tumours of the urinary system and male genital organs. World Health Organization classification of tumours. IARC Press, LyonFrance 2004
- Mommsen S, Aagaard J, Sell A. Presenting symptoms, treatment delay and survival in bladder cancer. Scand J Urol Nephrol 1983; 17: 163–7
- Liedberg F, Anderson H, Månsson Å, Månsson W. Diagnostic delay and prognosis in invasive bladder cancer. Scand J Urol Nephrol 2003; 37: 396–400
- Arbman G, Nilsson E, Störgren-Fordell V, Sjödahl R. A short diagnostic delay is more important for rectal cancer than for colonic cancer. Eur J Surg 1996; 152: 899–904
- Gulliford MC, Petruckevitch A, Burney PG. Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment. Br Med J 1991; 202: 437–40
- Chang BS, Kim HL, Yang XJ, Steinberg GD. Correlation between biopsy and radical cystectomy in assessing grade and depth of invasion in bladder urothelial carcinoma. Urology 2001; 57: 1063–6
- Chang SS, Hassan JM, Cookson MS, Wells N, Smith JA. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 2003; 170: 1085–7
- O'Rourke N, Edwards R. Lung cancer treatment waiting times and tumour growth. Clin Oncol (R Coll Radiol) 2000; 12: 141–4
- Holmäng S, Hedelin H, Anderström C, Holmberg E, Johansson SL. The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study. J Urol 1997; 157: 800–4
- Hasan ST, German K, Derry CD. Same day diagnostic service for new cases of haematuria—a District General Hospital experience. Br J Urol 1994; 73: 152–4
- Soloway MS, Bruck DS, Kim SS. Expectant management of small, recurrent, non-invasive papillary bladder tumors. J Urol 2003; 170: 438–41
- Oldbring J, Glifberg I, Mikulowski P, Hellsten S. Carcinoma of the renal pelvis and ureter following bladder carcinoma: frequency, risk factors and clinicopathological findings. J Urol 1989; 141: 1311–3
- Messing EM, Young TB, Hunt VB, Gilchrist KW, Newton MA, Bram LL, et al. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. Urology 1995; 94: 387–95
- Primdahl H, Nielsen AL, Larsen S, Andersen E, Ipsen M, Lajer C, et al. Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: a Danish nationwide survey from DAHANCA. Acta Oncol 2006; 45: 156–61